A multiple imputation approach 16 was used in which missing data were imputed by sampling from available measurements at week 68 from participants in the same treatment group and with the same treatment completion status
Standard semaglutide pens deliver a minimum of 0.25 mg per dose
Due to its shorter duration of action, liraglutide requires daily dosing to maintain effective levels in the system
A study examined a gabapentin dose of 100mg given every 8 hours, which demonstrated a bioavailability of approximately 80%, however, when the dose was increased to 1600mg every 8 hours, the average bioavailability decreased to 27%
Hypoglycemia less than 54mg/dL was reported in 6.7%, 5.5% and 6.5% of patients treated with tirzepatide 5mg, 10mg, and 15mg, respectively, and in 15% of those who received insulin glargine
So, the better question is not which one is better? The better research question is: which peptide fits the study model